Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brigitte Sturm

Showing results (21-30 of 23) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 23 results.
Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging|September 11, 2013
White matter changes in patients with friedreich ataxia after treatment with erythropoietinKarl Egger, Christian Clemm von Hohenberg, Michael F Schocke, et al.
Analytical Biochemistry|May 24, 2005
Results of an international round robin for the quantification of serum non-transferrin-bound iron: Need for defining standardization and a clinically relevant isoformEsther M G Jacobs, Jan C M Hendriks, Berry L J H van Tits, et al.
Journal of Neurology|April 8, 2015
An open-label trial in Friedreich ataxia suggests clinical benefit with high-dose resveratrol, without effect on frataxin levelsEppie M Yiu, Geneieve Tai, Roger E Peverill, et al.
Pageof 3

Showing results (21-30 of 23) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 23 results.
Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging|September 11, 2013
White matter changes in patients with friedreich ataxia after treatment with erythropoietinKarl Egger, Christian Clemm von Hohenberg, Michael F Schocke, et al.
Analytical Biochemistry|May 24, 2005
Results of an international round robin for the quantification of serum non-transferrin-bound iron: Need for defining standardization and a clinically relevant isoformEsther M G Jacobs, Jan C M Hendriks, Berry L J H van Tits, et al.
Journal of Neurology|April 8, 2015
An open-label trial in Friedreich ataxia suggests clinical benefit with high-dose resveratrol, without effect on frataxin levelsEppie M Yiu, Geneieve Tai, Roger E Peverill, et al.
Pageof 3